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Abstract
Parasitic nematodes produce an unusual class of fatty acid and retinol (FAR)-binding pro-
teins that may scavenge host fatty acids and retinoids. Two FARs from Brugia malayi (Bm-
FAR-1 and Bm-FAR-2) were expressed as recombinant proteins, and their ligand binding,
structural characteristics, and immunogenicities examined. Circular dichroism showed that
rBm-FAR-1 and rBm-FAR-2 are similarly rich in α-helix structure. Unexpectedly, however,
their lipid binding activities were found to be readily differentiated. Both FARs bound retinol
and cis-parinaric acid similarly, but, while rBm-FAR-1 induced a dramatic increase in fluo-
rescence emission and blue shift in peak emission by the fluorophore-tagged fatty acid (dan-
syl-undecanoic acid), rBm-FAR-2 did not. Recombinant forms of the related proteins from
Onchocerca volvulus, rOv-FAR-1 and rOv-FAR-2, were found to be similarly distinguish-
able. This is the first FAR-2 protein from parasitic nematodes that is being characterized.
The relative protein abundance of Bm-FAR-1 was higher than Bm-FAR-2 in the lysates of
different developmental stages of B. malayi. Both FAR proteins were targets of strong IgG1,
IgG3 and IgE antibody in infected individuals and individuals who were classified as
endemic normal or putatively immune. In a B. malayi infection model in gerbils, immuniza-
tion with rBm-FAR-1 and rBm-FAR-2 formulated in a water-in-oil-emulsion (®Montanide-
720) or alum elicited high titers of antigen-specific IgG, but only gerbils immunized with rBm-
FAR-1 formulated with the former produced a statistically significant reduction in adult
worms (68%) following challenge with B. malayi infective larvae. These results suggest that
FAR proteins may play important roles in the survival of filarial nematodes in the host, and
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Author summary
Human lymphatic filariasis (LF) and river blindness (onchocerciasis) are highly debilitat-
ing neglected tropical diseases. As with all parasitic nematodes, Wuchereria bancrofti, Bru-
gia malayi and Brugia timori, the etiological agents of LF and Onchocerca volvulus the
causative agent of river blindness, possess limited lipid metabolic pathways and hence rely
on lipids scavenged from their human hosts. Two unusual lipid-trafficking proteins from
Brugia malayi (Bm-FAR-1 and Bm-FAR-2) were expressed as recombinant proteins, and
their ligand binding activities along with their structural characteristics were examined.
Their immunogenicity in infected children and those who are classified as endemic nor-
mal or putatively naturally immune were also evaluated. Their immunogenicity and
immunoprotective efficacies were also evaluated in a B. malayi gerbil infection model.
The possible role these proteins play in the survival of filarial nematodes in the host, and
their prospects of being candidates for vaccine against these highly pathogenic infections
are discussed.
Introduction
Human lymphatic filariasis (LF) and river blindness (onchocerciasis) are highly debilitating
diseases in tropical developing countries with an estimated disease prevalence of 29.38 and
14.65 million cases that cause 1.2 and 0.96 million years lived with disability (YLD), respec-
tively [1]. As with all parasitic nematodes, the etiological agents of LF such as Wuchereria ban-
crofti, Brugia malayi and Brugia timori, and that of river blindness, Onchocerca volvulus,
possess limited lipid metabolic pathways and hence rely on lipids scavenged from their hosts
[2]. Several structurally novel families of lipid-binding proteins in nematodes have been
reported [3], including the fatty acid- and retinoid-binding protein family (FAR) that have
been identified from many species of filarial nematodes including those from the genera Onch-
ocerca, Brugia, Wuchereria, Loa, Acanthocheilonema and Litomosoides [4]. FAR proteins repre-
sent a structurally novel class of approximately 20 kDa lipid-binding proteins that are only
found in nematodes [5], isoforms of which are known to be differentially expressed during
development of parasitic and free-living species [5–7].
Ov-FAR-1 (previously known as Ov20 or Ov-RBD-1), a FAR protein from the filarial nema-
tode O. volvulus was initially identified as a 20 kDa, structurally novel small helix-rich fatty
acid and retinol (vitamin A)-binding protein secreted by the adult worm [8]. Soon thereafter,
Bm-FAR-1, was described in B. malayi, and the two proteins were found to have similar sec-
ondary structure and ligand-binding characteristics [2, 4]. PCR-based strategies have since
been used to isolate cDNAs encoding FARs from the filarial nematodes Onchocerca, Brugia,
Wuchereria, Loa, Acanthocheilonema and Litomosoides [2, 4].
The ligand-binding properties of the filarial FAR proteins have been suggested to contrib-
ute, not only to their survival in the host, but also to pathogenesis in mammalian hosts [5, 8,
9]. These parasites appear to require retinoids and fatty acids for a variety of metabolic and
developmental needs, including growth, development, differentiation, embryogenesis, and gly-
coprotein synthesis [2, 5, 10, 11]. FAR proteins have been shown to be released from the
Brugia malayi fatty acid and retinol binding proteins
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parasites into their hosts [2, 8, 12], suggesting that their FARs may also play an important role
in modifying the local inflammatory and immunological environment of the surrounding host
tissue by sequestering and/or delivering pharmacologically active lipids [5, 12]. Relevant to
this hypothesis is the finding of high concentrations of retinol within onchocercal nodules
[13]. Given the role of retinoids in vision, tissue differentiation and collagen synthesis [9], such
sequestration of retinol might exacerbate vitamin A deficiency in infected humans, thereby
contributing to the clinical manifestation of river blindness. It has been found that patients
with onchocerciasis have lower serological level of vitamin A [14, 15].
The probable dependence of the filarial parasites on the FAR proteins for metabolic needs,
and their potential roles in development and immune modulation of the host makes them per-
tinent targets for anthelmintic drugs and vaccine development. We therefore produced two
FAR proteins from B. malayi in recombinant forms, biophysically characterised their hydro-
phobic ligand binding properties, and tested their immunogenicity and immunoprotective
efficacy against infection with B. malayi infective larvae in gerbils. We found that despite their
amino acid sequence relatedness and similar structural characteristics, and a precedent in
another species, rBm-FAR-1 and rBm-FAR-2 could be clearly discriminated by their ligand-
binding properties. We provide evidence that this disparity applies widely in filarial parasites.
Immunization with recombinant Bm-FAR-1 conferred significant protection against infection
in gerbils, but only when formulated in a water-in-oil adjuvant rather than alum. Our results
indicate that Bm-FAR-1 is a candidate for a vaccine development against lymphatic filariasis,
and related filarial helminthiases, and that Bm-FAR-2 might have to be further optimized
before confirmed to being a promising vaccine candidate.
Methods and materials
Ethics statement
All the animals in this study were handled according to the National Institutes of Health
(USA) guidelines and the animal experimentation was performed with prior approval from
the Louisiana State University Institutional Animal Care and Use Committee under the proto-
col number 12–037.
The protocols used in all the population studies were approved by the Institutional Review
Board (IRB) of the National Institute of Allergy and Infectious Diseases (Cook Islands studies,
clinical protocol number 92-I-0155), the New York Blood Center’s IRB (clinical protocol num-
ber 321 and 603–09), and by the National Institutes of Health (USA) accredited Institutional
Review Board of the Medical Research Council Kumba, Cameroon (Kumba studies, clinical
protocol number 001). Informed written consent was obtained from all adult subjects, and for
children consent was obtained through both verbal assent and written consent from each sub-
ject’s legal guardian.
Sequence analyses of Bm-FAR proteins
The encoded amino acid sequences of Bm-FAR-1 (GenBank accession# XP_001899742) and
Bm-FAR-2 (XP_001900470) were aligned with FAR proteins from other nematodes including
Wuchereria bancrofti (Wb-FAR-1:Q8WT54.2; Wb-FAR-2:EJW79208.1), Onchocerca volvulus
(Ov-FAR-1: Q25619.1; Ov-FAR-2: ACT55269.1), Loa loa (L1-FAR-1: AAK84218.1; Ll-FAR-2:
XP_003137038.2), Dirofilaria immitis (Di-FAR-1: nDi.2.2.2.t00119�; Di-FAR-2: nDi.2.2.2.
t02086�); Brugia pahangi (Bp-FAR-1: Q8WT55.2; Bp-FAR-2: BPAG_0000817001-mRNA-1�),
Litomosoides sigmodontis (Ls-FAR-1: Q8WT56.2; Ls-FAR-2: nLs.2.1.2.t01040-RA�), Acanthochei-
lonema viteae (Av-FAR-1: Q8MZJ8.1; Av-FAR-2: nAv.1.0.1.t08895-RA�), Ascaris suum (As-FAR-
1: ERG87764.1; As-FAR-2: ERG85173.1), Ancylostoma caninum (Ac-FAR-1: AAM93667.1;
Brugia malayi fatty acid and retinol binding proteins
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Ac-FAR-2: ANCCAN_08556�), Necator americanus (Na-FAR-1 (PDB: 4UET_A, XP_01329370
8.1; Na-FAR-2: NECAME_14206�), Toxocara canis (Tc-FAR-1: KHN72925.1; Tc-FAR-2:
KHN88420.1), Haemonchus contortus (Hc-FAR-: CDJ83169.1; Hc-FAR-2: HCOI00378700.t1�),
Caenorhabditis elegans (Ce-FAR-1: NP_001254978.1; Ce-FAR-7 (PDB: 2W9Y_A), Strongyloides
ratti (St-FAR-1: CEF68237.1), Ostertagia ostertagi (Oo-FAR-1: CAD20464.1). Similar sequences
marked with [�] were obtained by BLAST searching nematode genomes databases at Wormbase
(http://parasite.wormbase.org/index.html). A phylogenetic tree was generated using MEGALIGN
from Lasergene 14, DNASTAR), and rendered using FigTree 1.4.3. For structural comparison of
Bm-FAR-1 and Bm-FAR-2 with structure-defined orthologues Na-FAR-1 (PDB: 4UET_A) [16]
and Ce-FAR-7 (PDB: 2W9Y_A) [17], the sequences were aligned with Clustal Omega and the sec-
ondary structural features were predicted based on the coordinates of Na-FAR-1 and Ce-FAR-7
using ESPript [18]. The structural theoretical ‘homology’ models of Bm-FAR-1 and Bm-FAR-2
were generated using Swiss model [19, 20].
Production of recombinant Bm-FAR and Ov-FAR proteins
For production of recombinant proteins, the DNAs encoding Bm-FAR1 and Bm-FAR-2
(minus their signal peptides) were codon optimized for yeast preference and synthesized by
GenScript (Piscataway, NJ, USA), and then inserted in-frame into the PichiaPink expression
vector pPinkα-HC (Invitrogen, Carlsbad, USA) using XhoI/KpnI sites. The recombinant pro-
teins with 6His-tag at C-terminus were induced in PichiaPink strain 4 (with protease PEP4
and PRB1 deleted to reduce degradation) with 5% methanol and purified with immobilized
metal affinity chromatography (IMAC) as previously described [21, 22]. Due to the high levels
of glycosylation of the yeast expressed Bm-FAR-2 recombinant protein, it was re-cloned in E.
coli expression vector pET41a (Novagen, USA) with glutathione-S-transferase-tag deleted
(NdeI/XhoI), and then transformed into BL21(DE3) cells (Novagen, USA). Recombinant Bm-
FAR-2 protein (rBm-FAR-2) was induced with 1 mM IPTG and purified with IMAC as
described [23]. The rBm-FAR-1 expressed in yeast, and the rBm-FAR-2 expressed in E. coli
were used for subsequent binding activity and vaccination experiments. The recombinant pro-
teins of FAR orthologues in O. volvulus (rOv-FAR-1 and rOv-FAR-2) were produced in E. coli
using similar procedures as rBm-FAR-2.
Parasite stage-specific expression of Bm-FAR proteins
Stage-specific proteomic expression patterns for the adult B. malayi male (AM) and female
(AF) parasites, microfilariae (MF), immature MF (intrauterine stages; UTMF), and the third-
stage larvae (L3) were derived from the B. malayi somatic proteomes [24], and normalized
using normalized spectral abundance factor (NSAF), where the relative abundance of a protein
in a sample was calculated by: NSAF ¼
ð
Spectra
LengthÞpXn
p¼1
ð
Spectra
length Þp
.
The in-vitro derived L4 [25] were lysed in lysis buffer, dialyzed, desalted, and digested with
trypsin. The cation-exchange liquid chromatography fractionation of tryptic peptides was ana-
lyzed by nanobore reverse-phase liquid chromatography (RPLC-MS/MS). Proteins were iden-
tified by searching the spectral data using PEAKS 7 using a combined database of B. malayi
(Wormbase WBPS9 ver) and its endosymbiont Wolbachia (wBm).
Circular dichroism (CD)
A Jasco-J1100 CD Spectrophotometer was used for measurements in the far ultraviolet region
(UV), from 190 to 260 nm. Spectra were recorded at protein concentrations of approximately
Brugia malayi fatty acid and retinol binding proteins
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0.1–0.2 mg ml-1 in a cuvette of 0.2 mm path length in a temperature-controlled cell holder at
25˚C. Spectra were monitored with a 0.2-nm step with 10 averages per step. Samples were pre-
pared in 20 mM Tris, 20 mM NaCl, pH 6.8 buffer, and all spectra were baseline corrected by
subtraction of the spectra for buffer alone. Analysis of the CD spectra was undertaken using
the CDSSTR within the Dichroweb program [26, 27].
Fluorescence-based lipid binding assays
Recombinant FAR proteins of B. malayi and O. volvulus (rBm-FAR-1, rBm-FAR-2, rOv-FAR-
1 and rOv-FAR-2), were used in fluorescence-based lipid binding assays as previously
described [5, 12, 28]. The concentrations of the proteins were estimated by absorbance at 280
nm (correcting for any untoward absorbances at 230 and 260 nm), using theoretical extinction
coefficients based on their amino acid compositions, and calculated using the ProtParam tool
online at http://web.expasy.org/protparam. The protein concentrations of all were calculated
to be at approximately 4 mg ml-1. Lipid binding was detected spectrofluorometrically, using
all-trans retinol, or the fluorescent fatty acid analogue 11-((5-dimethylaminonaphthalene-
1-sulfonyl)amino)undecanoic (DAUDA), which bears the environment-sensitive dansyl fluor-
ophore, or with the intrinsically fluorescent cis-parinaric acid (cPnA), all as described before
[5]. DAUDA and cPnA were obtained from Molecular Probes/Invitrogen (Renfrew, UK). All-
trans-retinol and oleic acid were obtained from Sigma (Poole, Dorset, UK). The excitation
wavelengths were 345 nm, 350 nm, and 319 nm for DAUDA, retinol, and cPnA, respectively,
all of which were at final concentrations of approximately 1 μM, 4 μM, and 4 μM, respectively,
in 2 ml phosphate buffered saline (PBS) pH 7.2 in a quartz fluorescence cuvette. Binding of a
non-fluorescent ligand was detected by a reversal of fluorescence emission enhancement elic-
ited by a test protein upon addition of the ligand to a preformed DAUDA:protein complex.
Note that rBm-FAR-2 is larger than rBm-FAR-1, so at equivalent w/v concentrations their
molarities will differ. Also, we cannot assume that the proportion of properly folded and active
protein in each protein sample is equivalent, or that there is no interference from resident
ligand(s) derived from the bacteria in which the proteins were produced despite routine deter-
gent and lipid depletion–our experience is that complete removal of resident lipids from nem-
atode lipid-binding proteins requires methods such as reverse-phase chromatography [29],
which was not carried out in the present study. The fluorescence spectra are uncorrected and
were analyzed using MICROCAL ORIGIN software.
Antibody responses to Bm-FARs and Ov-FARs in infected, endemic normal
and/or putatively immune humans
The serum samples used for the present studies were from a repository from two distinct clini-
cal studies in which plasma samples were collected from two different populations. First, two
population studies performed in 1975 and 1992 in the island of Mauke in the Southern Cook
Islands, a region endemic for the filarial parasite W. bancrofti. The characteristics of the popu-
lation studied have been described in detail in previous publications [30, 31]. Second, a clinical
study performed between 1995 and 2000 in the Kumba region of southwest Cameroon, an
area of hyperendemicity for onchocerciasis. The characteristics of this population have also
been described previously [32, 33]. Antibody responses to rBm-FAR-1 and rBm-FAR-2 were
tested in children (age 2–9) that were infected (INF; n = 21; microfilaremic and/or positive for
circulating filarial antigen) or classified as uninfected or endemic normal (EN; n = 22). Anti-
body responses to rOv-FAR-1 and rOv-FAR-2 were tested in putatively immune (PI; n = 12;
age 5–59), and age and sex match infected (INF; n = 30; 6–41) individuals.
Brugia malayi fatty acid and retinol binding proteins
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Sera obtained from the individuals were analyzed for IgG1, IgG3 and IgE isotype antibody
responses using recombinant Bm-FARs and Ov-FARs using ELISA protocols established for test-
ing antibody responses to filarial recombinant proteins [30–32, 34–36], with some modification.
Briefly, each recombinant protein (1 μg/ml) was used to coat the wells of ELISA plates, and sera at
a 1:100 (IgG1 and IgG3) or at 1:50 (IgE) dilution were applied. The bound IgG1 or IgG3 antibod-
ies were detected by using a 1:1,000 dilution of monoclonal antibodies against human IgG1 and
IgG3 subclasses (Hybridoma Reagent Laboratory, Kingsville, MD). This step was followed by
incubation with a 1:1,250 dilution of horseradish peroxidase (HRP)-conjugated rabbit anti-mouse
immunoglobulins (Kierkegaard & Perry Laboratories, Inc., Gaithersburg, Md.). Tetramethylben-
zidine (Sigma) was used as the chromogen, and the optical density (OD) was read at 450 nm. For
IgE responses, 1:1,000 dilution of monoclonal biotin conjugated anti-human IgE antibody
(Hybridoma Reagent Laboratory, Kingsville, MD) followed by incubation with 1:1,000 Streptavi-
din -HRP (Invitrogen) and 0.4 mg/ml of o-Phenylenediamine dihydrochloride (Sigma) dissolved
in phosphate citrate buffer with 0.05%H2O2. The optical density (OD) was read at 492nm. A pool
of 10 normal human sera from de-identified New York blood donors was used as a negative con-
trol, and for setting up the cutoff; mean OD ± 3X SD.
Animals and parasites
Mongolian gerbils, obtained from Charles River (Wilmington, MA, USA) at 8–10 weeks of
age, were maintained on standard rodent diet and water ad libitum. Infective third-stage larvae
(L3) of B. malayi were recovered from infected Aedes aegypti mosquitoes using the previously
described Baermann technique [37]. All the animals in experimental and control groups
received 100 B. malayi L3 subcutaneously in 0.5 ml of RPMI-1640 medium.
Immunization and challenge infection
The rBm-FAR-1 and rBm-FAR-2 were formulated with alum (Rehydragel LV, General Chemical,
NJ) at ratio of 1:8 (w/w) (25 μg of recombinant protein was mixed with 200 μg of alum) for 30
min at room temperature with shaking [21]. The virtually complete binding of recombinant FAR
proteins to alum was confirmed by SDS-PAGE. Ten 8–10 weeks old male Mongolian gerbils in
each group were immunized intraperitoneally (IP) with 25 μg of rBm-FAR-1 formulated with
alum as described above or emulsified with Montanide-720 (Seppic, Paris, France) at ratio of 30/
70 (v/v) in a total volume of 100 μl. Gerbils were boosted twice with the same dose at two-week
intervals. Another two groups of gerbils were intraperitoneally injected with PBS formulated with
the same adjuvants (alum or Montanide-720) as controls using the same regimen. Sera were col-
lected one week after each immunization. IgG responses to rBm-FAR-1 or to rBm-FAR-2 were
measured as previously described [38]. Serial dilutions of gerbil serum were made, and total anti-
gen-specific IgG response to recombinant antigens were evaluated for each group.
Two weeks after the third immunization, all gerbils in each group were challenged subcuta-
neously with 100 infective L3 of B. malayi. Necropsy was performed 42 days post-infection
and adult worms were recovered from different body regions of gerbils as described previously
[38, 39]. Protective immunity induced by immunization is expressed as the percentage reduc-
tion in worm burden as calculated by subtracting the average number of worms recovered in
immunized gerbils from the average number of worms recovered from the adjuvant control
gerbils divided by average worms recovered from control gerbils and then multiplied by 100.
Statistics
Analysis of human antibody response data was carried out using the non-parametric Mann-
Whitney test to examine statistical significance between the immune responses of infected and
Brugia malayi fatty acid and retinol binding proteins
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0006772 October 8, 2018 6 / 20
EN (uninfected) and putatively immune individuals to FAR proteins. For the immunization
experiments in gerbils, every experiment comprised 10 gerbils per group, and statistical analy-
sis between antigen-vaccinated groups and adjuvant control groups were performed using the
Mann-Whitney U test in GraphPad Prism 6 (GraphPad Software, San Diego, California USA).
Data were expressed as means ± standard deviation. A value of p< 0.05 was considered as sta-
tistically significant.
Results
Sequence and structural analysis of Bm-FAR-1 and Bm-FAR-2
Bm-FAR-1 was the first fatty acid and retinol binding protein identified in B. malayi with α-
helix-rich structure and lipid binding activity similar to Ov-FAR-1, its orthologue from O. vol-
vulus [2, 5]. BLAST searching of the B. malayi genome database [40] revealed a paralogous
FAR protein, here designated Bm-FAR-2. Both Bm-FAR-1 and Bm-FAR-2 contain the consen-
sus casein kinase II phosphorylation site which has been found in the same position in the
amino acid sequence in other FAR proteins [2, 7, 41]. The present study is the first to our
knowledge that characterizes a FAR-2 protein from a parasitic nematode.
Phylogenetic analysis shows that Bm-FAR-1 and Bm-FAR-2 fall into different clades of
nematode FARs. Bm-FAR-1 is closely related to putative FAR-1 homologues from other filar-
iae such as B. pahangi (Bp-FAR-1, 99% amino acid identity), W. bancrofti (Wb-FAR-1, 97%),
and O. volvulus (Ov-FAR-1, 82%) [2]. Bm-FAR-2 shares only 27% amino acid sequence iden-
tity to Bm-FAR-1 and possesses an unique N-linked glycosylation site at 53-NFS and 70 addi-
tional C-terminus amino acids, but instead is more similar to FAR-2 orthologues from closely
related species (88% sequence identity with Wb-FAR-2, and 63% with Ov-FAR-2) (Fig 1A and
1B). Molecular structures of two nematode FARs have been reported, one from Necator ameri-
canus (Na-FAR-1 by protein nuclear magnetic resonance (NMR) and x-ray crystallography;
PDB accessions 4UET and 4XCP, respectively) [16], and another from Caenorhabditis elegans
(Ce-FAR-7, by x-ray crystallography; PDB: 2W9Y) [17]. Notably, the molecular structure of
Na-FAR-1 revealed a surface-proximal and a deeper binding pocket for hydrophobic ligands
that are accessible to palmitate molecules.
Both Bm-FAR-1 and Bm-FAR-2 share less than 32% amino acid sequence identity with
either Na-FAR-1 or Ce-FAR-7. However, these structures proved to be useful for generating
theoretical models of Bm-FAR-1 and Bm-FAR-2 using Swiss-Model [19, 20]. The structure-
based comparison of the sequences using ESPript [18] reveals that the amino acids in the bind-
ing pockets of Bm-FAR-1 are more similar to Na-FAR-1, while those of Bm-FAR-2 are more
similar to Ce-FAR-7 (Fig 1B). The two distinct pockets in filarial nematode FARs are evident
in the predicted structures (Fig 1B & 1C). The deeper pocket (P1) may bind retinol whereas
the exterior pocket (P2) may bind fatty acids [16, 17]. The putative retinol-binding pocket P1
is formed by helices α2 and α6, which are well conserved (Fig 1B). The putative fatty acid bind-
ing cavity P2 is formed by helices α4 and α5, which are poorly conserved (Fig 1B). While the
putative retinol-binding pocket (P1) is similarly located and oriented in both models, the
potential fatty acid binding cavity (P2) is smaller and less accessible in Bm-FAR-2 than Bm-
FAR-1 (Fig 1C), which may explain the differences between the two proteins in their binding
of one of our fluorescent fatty acid probes (see below).
Higher abundance of Bm-FAR-1 in different stages of B. malayi
The normalized spectral abundance levels of Bm-FAR-1 and Bm-FAR-2 in the lysates of differ-
ent stages of B. malayi showed that the mature microfilariae (MF) and the immature uterine
microfilariae (UTMF) only exhibited very low-levels of either Bm-FAR-1 or Bm-FAR-2.
Brugia malayi fatty acid and retinol binding proteins
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Overall, Bm-FAR-1 was more abundant than Bm-FAR-2 across all the stages, with the adult
male worm and L4 stages exhibiting the highest abundance (4-fold and ~7-fold respectively)
(Fig 2). The similar abundances of both proteins in the adult female (containing both mature
and immature MFs) suggest that the source of the proteins is primarily the adult female.
Production of recombinant Bm-FAR-1 and Bm-FAR-2 proteins in E. coli
The rBm-FAR-1 protein was expressed in yeast and rBm-FAR-2 was expressed in E. coli. The
purified rBm-FAR-1 and rBm-FAR-2 were observed to migrate at their corresponding molecu-
lar sizes of ~19 kDa and 27kDa, respectively, on SDS-PAGE (Fig 3). The additional lower
molecular size bands for rBm-FAR-2 were reactive to anti-His antibody and so were likely deg-
radation products of the protein (S1 Fig). Both rBm-FAR-1 and rBm-FAR-2 were essentially
fully absorbed by the alum-based adjuvant (Fig 3).
Fig 1. Sequence and structural analysis of Bm-FAR-1 and Bm-FAR-2. (A) Phylogenetic tree of Bm-FAR-1 and Bm-FAR-2 and their homologues in other nematodes,
with bootstrap values (B) Structure based sequence comparison of Bm-FAR-1 and Bm-FAR-2, as well as Ov-FAR-1 and Ov-FAR-2, with Na-FAR-1 and Ce-FAR-7. The
sequences are aligned with Clustal Omega and the secondary structural features are illustrated with the coordinates of Na-FAR-1 and Ce-FAR-7 using ESPript [52]. The
different secondary structure elements shown are alpha helices (α), 310-helices (η), beta strands (arrows), and beta turns (TT). Identical residues are shown in solid red,
and conserved residues are in red. Black box indicates the conserved casein kinase II phosphorylation site. The N-glycosylation site at 53-NFS for Bm-FAR-2 and Ov-
FAR-2 is underlined. The amino acid sequence identity of orthologues between B. malayi and O. volvulus is shown at the end of sequence alignment. (C) Predicted
tertiary structures of Bm-FAR-1 and Bm-FAR-2 showing retinol-binding pocket (P1) and fatty acid binding pocket (P2). The palmitate molecules from the Na-FAR-1
structure are modeled into the pockets as magenta spheres. Top panel shows transparent surfaces of the models and the retinol-binding pocket P1 is formed by helices
α2 and α6, which are well conserved. The fatty acid binding cavity P2 is formed by helices α4 and α5, which are poorly conserved. The bottom panel of the solid surface
plot shows that the retinol-binding pockets (P1) are similarly located and oriented in both models, whereas the fatty acid binding pockets (P2) are smaller and less
accessible in Bm-FAR-2.
https://doi.org/10.1371/journal.pntd.0006772.g001
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Secondary structure content of Bm-FAR-1 and Bm-FAR-2
Both rBm-FAR-1 and rBm-FAR-2 were examined using circular dichroism, which showed
that both proteins are α-helix-rich, with negative molar ellipticity (Ɵ) values at 222 nm and
208 nm, and a positive value at 193 nm [42]. The calculated helicity for both proteins is 75%,
while the control protein rOv-FAR-2, the presumed orthologue of Bm-FAR-2 from O. volvu-
lus, contained 67% helicity (Fig 4). The high degree of helical structure for both Bm-FAR-1
and Bm-FAR-2, as estimated by CD, are similar to the predictions from homology modelling
and sequence analyses, which indicate a predominance of α-helices (Fig 1B).
Lipid binding by rBm-FAR-1 and rBm-FAR-2
The fatty acid and retinol binding properties of rBm-FAR-1 and rBm-FAR-2 were investigated
using a fluorescence-based lipid binding assay. Addition of retinol to either rBm-FAR-1 or
rBm-FAR-2 resulted in substantial increases in fluorescence emission, indicative of entry of
retinol into an apolar protein binding site (Fig 5A). When the fluorescent fatty acid analogue,
11-(dansylamino) undecanoic acid (DAUDA), was used as test ligand, rBm-FAR-1 produced a
large increase in DAUDA emission and a substantial blue-shift in the wavelength of peak fluo-
rescence emission from 542 to 483 nm (Fig 5B). This degree of blue shift in DAUDA’s emis-
sion is indicative of entry into a highly apolar environment and isolation from solvent water.
In contrast, rBm-FAR-2 produced a mild enhancement in DAUDA fluorescence, indicating
that rBm-FAR-2 interacts poorly with DAUDA, or that it does bind this ligand but in a way
that leaves the attached dansyl fluorophore still in a polar environment (Fig 5B). Addition of
oleic acid to preformed DAUDA: rBm-FAR-1 complexes resulted in a significant decrease in
the fluorescence intensity, indicating displacement of DAUDA from the binding site into
polar solvent, and probable congruence between the binding sites for the two lipids (Fig 5C).
Both rBm-FAR-1 and rBm-FAR-2 bound cPnA, which is an intrinsically fluorescent fatty acid
that does not bear a bulky attached fluorophore (as is the case for DAUDA) (Fig 5D). The
Fig 2. Bubble plot showing the normalized spectral abundance levels of BmFAR-1 and BmFAR-2 across the
mature microfilaria (MF), immature microfilariae (UTMF), L3 larvae, in-vitro derived L4 larvae (L4), adult
female (AF) and male (AM) worms based on proteomic analysis. The size of the bubble is proportional to the
abundance of Bm-FAR-1.
https://doi.org/10.1371/journal.pntd.0006772.g002
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enhancement of cPnA’s fluorescence emission with rBm-FAR-2 was less than that with rBm-
FAR-1, which may be due to fundamental differences in their hydrophobic ligand-binding
properties, or that the former protein’s population may not have been proportionately as well
folded as the latter’s (despite their retinol- and cPnA-binding activities being similar here), or
that the environment of their binding sites for cPnA are slightly different. Essentially, however,
both rBm-FAR-1 and rBm-FAR-2 bind fatty acids and retinol (and possibly other hydrophobic
ligands), but can be discriminated by activity with DAUDA.
In parallel experiments, rOv-FAR-1 and rOv-FAR-2, which are presumed orthologues of
rBm-FAR-1 and rBm-FAR-2, respectively, behaved in the fluorescence assays similarly to their
counterpart Bm-FARs (S2 Fig).
Antibody responses to rBm-FARs and rOv-FARs in infected, endemic
normal and putatively immune humans
When the rBm-FARs antigen-specific IgG1 and IgG3 responses in sera from infected (INF) or
exposed but uninfected/endemic normal (EN) children living in W. bancrofti endemic region,
Fig 3. SDS-PAGE of yeast expressed rBm-FAR-1 and E. coli expressed rBm-FAR-2 and their binding to alum
(Rehydrogel). Two μg of recombinant proteins were loaded in each lane (red arrow). The same amount of
recombinant proteins was absorbed with Rehydrogel and the absorbed supernatant was loaded to adjacent well.
https://doi.org/10.1371/journal.pntd.0006772.g003
Brugia malayi fatty acid and retinol binding proteins
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0006772 October 8, 2018 10 / 20
and the rOv-FARs antigen-specific IgG1, IgG3 and IgE responses in sera from O. volvulus
putatively immune (PI) or infected individuals (INF) were performed (Fig 6), it appears that
both FAR proteins are immunogenic in all groups tested; no statistical differences were
observed between the INF and EN children living in W. bancrofti endemic region (Fig 6A and
6B) or the PI and INF individuals living in onchocerciasis endemic region (Fig 6C and 6D).
However, it appears that both proteins are more immunogenic in the O. volvulus endemic
population as the number of IgG1 and IgG3 responders to rOv-FAR-1 and to rOv-FAR-2 anti-
gens was similarly high in both the PI and INF groups (>92% IgG1 responders to both anti-
gens; >93% IgG3 responders to both antigens). The IgE responses were more modest; the
number of IgE responders to rOv-FAR-1 and to rOv-FAR-2 antigens in the PI was 58.3% and
33.3%, respectively (Fig 6C and 6D), while the number of IgE responder in the INF was 76.7%
and 46.7%, respectively (Fig 6E). In comparison, only the number of the IgG3 responders to
rOv-FAR-2 antigen in the infected (INF) or the exposed but uninfected (EN) children from
the W. bancrofti endemic region was higher; 90.4% and 72.7%, respectively. The number of
IgG1 responders to rBm-FAR-1 and to rBm-FAR-2 antigens was only 50%-66.6%, while the
number of IgG3 responders to rBm-FAR-1 antigens was 40.9–66.6%. No IgE responses were
detected against any of the rBm-FAR-1 and to rBm-FAR-2 in both populations.
Immunization with rBm-FAR-1 induced partial protective immunity
against B. malayi infection in gerbils
After immunization with 25 μg of rBm-FAR-1 formulated with alum or Montanide-720 for
three times, and following challenge with 100 infective B. malayi L3, a significant reduction in
Fig 4. Circular dichroism spectra of rBm-FAR-1, rBm-FAR-2 and rOv-FAR-2 in 20 mM Tris, 20 mM NaCl, pH 6.8
TBS, 25 oC.
https://doi.org/10.1371/journal.pntd.0006772.g004
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worm numbers (68.4%, p = 0.0063) was observed only in the group of gerbils immunized with
rBm-FAR-1 formulated with Montanide-720 (Fig 7A). After immunization with 25 μg of rBm-
FAR-1 formulated with alum or Montanide-720 for three times, and following challenge with
100 infective B. malayi L3 in two separated experiments, a combined total worm reduction of
68.4% was observed with statistical significance (p = 0.0063) in the group of gerbils immunized
with rBm-FAR-1 formulated with Montanide-720 compared to adjuvant control group (Fig
7A). The worm reductions for individual rBm-FAR-1/Montanide-720 immunization were
68.0% (p = 0.0139) and 44.4% (p = 0.0541), respectively, compared to adjuvant control.
Though a trend of reduction (38.5%) was observed with the alum formulation, it was not sta-
tistically significantly different (p = 0.1458) from its corresponding alum control (Fig 7A). The
efficacy outcomes have been assembled from two experiments done in separate times. The dif-
ferences in protection between the two vaccine formulation cannot be simply accounted for by
the overall anti-IgG rBm-FAR-1 antibody titers; the titers in both vaccinated groups after three
immunizations and before challenge were similar (geometric mean of 4.81 x 105 and 5.15 x
105, in alum or Montanide-720 formulated rBm-FAR-1 vaccines, respectively) (Fig 7B).
Under the same immunization regimen, gerbils immunized with rBm-FAR-2 formulated
with alum or Montanide-720 only produced 16% and 42% of adult worm reduction,
Fig 5. Lipid binding properties of rBm-FAR-1 and rBm-FAR-2. Fluorescence emission spectra were recorded, and
spectrofluorimetry conditions set, as described in Materials and Methods. (A) Retinol in ethanol was added to 2 ml
PBS, pH 7.2 (to create an approximately 4 μM solution of retinol) alone, or 2 ml PBS containing rBm-FAR-1 or rBm-
FAR-2. Both proteins clearly bind retinol. (B) When rBm-FAR-1 and rBm-FAR-2 were added to 2 ml of an
approximately 1 μM solution of DAUDA in PBS, Bm-FAR-1 elicited a dramatic increase and blue shift in DAUDA
fluorescence emission, whereas Bm-FAR-2 did so to a minimal extent. (C) Addition of oleic acid to pre-formed Bm-
FAR-1:DAUDA complexes results in competitive displacement of DAUDA from the protein binding site, indicating
that there exists a binding site with preference for natural fatty acids. (D) Both proteins bind cis-parinaric acid (cPnA),
albeit yielding different amplitudes of change in cPnA emission, but this nevertheless indicates that both proteins bind
fatty acids. Similar experiments were carried out with the orthologues of these proteins from the river blindness
parasite O. volvulus (rOv-FAR-1 and rOv-FAR-2) and the results were directly comparable to results with the Bm-
FARs (see S2 Fig).
https://doi.org/10.1371/journal.pntd.0006772.g005
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respectively, neither was statistically significant (p = 0.402 and p = 0.0612, respectively) com-
pared with the respective adjuvant groups (Fig 6C, Table 1). In both immunized groups high
antibody titers against rBm-FAR-2 were nevertheless detected (geometric mean of 4.84 x 105
and 5.94 x 105, respectively) (Fig 6D).
Discussion
The unusual ligand binding properties and nematode-specific structures set FAR proteins
apart from mammalian lipid-bind proteins [5, 7]. The objectives of this study were to assess
the structural and ligand-binding characters of two FAR proteins from the filarial parasite B.
malayi, and evaluate their potential as vaccine candidates in gerbils. This is the first FAR-2 pro-
tein from a parasitic nematode that is being characterized.
The binding properties of rBm-FAR-1 in this study were consistent with previously
described results [2] in that rBm-FAR-1 was able to bind retinol and DAUDA. While rBm-
FAR-2 also bound retinol, in unexpected contrast to rBm-FAR-1, it did not produce the dra-
matic change in DAUDA’s emission observed with rBm-FAR-1. Both proteins, however,
bound cPnA, an unmodified intrinsically fluorescent fatty acid (Fig 5). The difference between
the ligand binding propensities of the two proteins is surprising given previous experience
with orthologous proteins in another species [7]. While there is no direct evidence of where in
Fig 6. IgG1, IgG3 and IgE antibody responses against Bm-FARs and Ov-FARs in human populations living in filariae endemic
regions. Anti-rBm-FAR-1 and rBm-FAR-2 IgG1 (A) and IgG3 (B) responses in children that were infected (INF) or uninfected (EN)
who lived in Cook Islands, an endemic region for lymphatic filariasis. Anti-rOv-FAR-1 and rOv-FAR-2 IgG1 (C), IgG3 (D) and IgE (E)
responses in putatively immune (PI) and infected (INF) individuals who lived in onchocerciasis highly endemic area in Cameroon. The
ODs obtained with a pool of 10 control normal human sera samples at 1:100 (IgG1 and IgG3) or 1:50 (IgE) dilution were used to
calculate the cutoff for each assay based on mean OD ± 3X SD (dotted line): 0.1 for anti-rBm-FAR-1 and anti-rBm-FAR-2 IgG1; 0.05
for anti-rBm-FAR-1 anti-rBm-FAR-2 IgG3; 0.135 for anti-rOv-FAR-1 and anti-rOv-FAR-2 IgG1; 0.08 for anti-rOv-FAR-1 and anti-
rOv-FAR-2 IgG3; and 0.1 for anti-rOv-FAR-1 and anti-rOv-FAR-2 IgE. The cutoff was used to calculate the number of responders,
individual having IgG1, IgG3 or IgE OD values more than mean + 3X SD of normal human sera. Analysis was done using the Mann-
Whitney test.
https://doi.org/10.1371/journal.pntd.0006772.g006
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Fig 7. Protective immunity induced by immunization of gerbils with rBm-FAR-1 and rBm-FAR-2 formulated with Montanide-720 or alum. (A)
Total worm count from gerbils (n = 20 per group, which are presented as a combination of two separate experiments) immunized with rBm-FAR-1
formulated with alum or Montanide-720 or adjuvant controls 42 days after being challenged with 100 B. malayi L3. (B) Titers of anti-Bm-FAR-1 IgG in
sera of gerbils immunized rBm-FAR-1 formulated with alum or Montanide-720. (C) Total worm count from gerbils (n = 10 per group performed only
once) immunized with rBm-FAR-2 formulated with alum or Montanide-720 or adjuvant controls. (D) Titers of anti-Bm-FAR-2 IgG in sera taken from
gerbils immunized with rBm-FAR-2 formulated with alum or Montanide-720. The median in A and C is marked by a line. Geometric mean and 95% CI
are marked in B and D.
https://doi.org/10.1371/journal.pntd.0006772.g007
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the two proteins retinol and fatty acids localize, the predicted tertiary structures of both pro-
teins reveal differences that may explain the differential binding properties. Bm-FAR-1 and
Bm-FAR-2 have similar putative retinol-binding pockets (P1), but Bm-FAR-2 has a smaller
and less accessible predicted cavity for fatty acid binding (P2) than Bm-FAR-1. These possible
structural differences are therefore consistent with the empirical finding that both proteins
bind retinol similarly, but that rBm-FAR-2 is more selective in its binding of fatty acids. In
addition to the difference in structure and binding activities, Bm-FAR-1 is more abundant in
all the stages of B. malayi than Bm-FAR-2, especially in the adult male adult worms and L4 lar-
val stages, suggesting that Bm-FAR-1 may play quite different role(s) in the maintenance of life
cycle than Bm-FAR-2. In A. lumbricoides, a FAR protein named ABA-1 is a major allergen was
found to bind retinol and a range of fatty acids, including the pharmacologically active lipids
lysophosphatidic acid, lysoplatelet activating factor, and leukotrienes [43]. To investigate
whether these proteins are also immunoregulatory, it will be of interest to use the fluores-
cence-based assay used here to screen both FAR proteins (and their orthologues in O. volvulus
and other species) for binding to immunologically- and inflammatory-related lipids such as
leukotrienes and prostaglandins, or their precursors such as arachidonic acid.
We found that both B. malayi and O. volvulus FAR proteins are the targets of strong cyto-
philic IgG1 and IgG3 antibody responses in infected humans, as well as in those individuals
classified as being protected (the EN and PI individuals). There is a difference between an anti-
gen being the target of immune responses in infected and naturally immune individuals and
their immunoprotective activity. We therefore proceeded to test the immunoprotective activity
of the Bm-FAR proteins in gerbils. The results of this indeed suggested that their vaccine
potential merits more extensive exploration, but also that Bm-FAR-1 and -2 may perform dif-
ferent functions in parasite survival. Gerbils immunized with rBm-FAR1 elicited statistically
significant protection against challenge of B. malayi L3, although this was dependent on the
adjuvant used. Gerbils immunized with rBm-FAR-2, on the other hand, were less protected,
regardless of which adjuvant was used, despite the IgG antibody titers induced against either
protein or adjuvant formulation being similar. The value of FAR proteins in protective immu-
nity has also been observed in immunization trials with a FAR homologue from O. volvulus
(Ov-FAR-1) against heterologous challenge of rodent filaria A. viteae in Mongolian gerbils
[44], and from the human and animal hookworms [45]. The mechanism underlying the pro-
tection and the difference in the vaccine efficacy of the two proteins remains to be determined.
The difference in their ligand binding properties and the expression abundance between Bm-
FAR-1 and Bm-FAR-2 suggests both FARs may function differently in the maintenance of the
parasite’s life cycle and interaction with host. The Bm-FAR-1 protein is more abundant after
molting of L3, by twofold, which may indicate that it is more vulnerable to immunological
Table 1. B. malayi adult worm recovery from gerbils immunized with adjuvant-formulated rBm-FAR-1 or rBm-FAR-2.
Vaccine Experiment Number Number of animals Adjuvant Mean worm ± SD % Worm reduction p value
Adjuvant Vaccine
rBm-FAR-1 1 10 Alum 4.7 ± 5.9 2.8 ± 2.8 40.4 0.6924
10 Montanide 7.5 ± 6.2 2.4 ± 1.6 68.0� 0.0139�
2 10 Alum 11.9 ± 5.8 7.4 ± 5.9 37.8 0.0546
10 Montanide 16.0 ± 8.3 8.8 ± 9.6 44.4 0.0541
rBm-FAR-2 3 10 Alum 11.9 ± 5.8 10.0 ± 8.8 16.0 0.402
10 Montanide 16 ± 8.3 8.9 ± 6.4 42.0 0.0612
� Statistically significant, Mann–Whitney U Test, p< 0.05
https://doi.org/10.1371/journal.pntd.0006772.t001
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attack than Bm-FAR-2. It cannot be excluded that the immuno-protective difference between
rBm-FAR-1 and rBm-FAR-2 may partially results from the different expression system, which
will need to be further confirmed in future experiments. In both Bm-FAR-1 and Bm-FAR-2
immunization, Montanide-720 adjuvant induced better protection than did alum. Montanide-
720 is a water-in-oil emulsion preparation that induces strong and broad Th1- and Th2-asso-
ciated humoral and cellular immune responses [46, 47], while alum is known to stimulate a
Th2-type humoral and cellular response [48]. The adjuvants used here may therefore elicit dif-
ferent immunoglobulin isotype dominances (e.g. different IgG isotype balances, or IgE) and T
cell response biases that may contribute to the difference of protection. Due to the lack of
reagents for detecting IgG subclasses and cytokines in gerbils, the nature and biases of immune
response induced with different adjuvants remains to be examined. Protection against filarial
infection in humans appears to be associated with a combination of IgG1, IgG3 and IgE anti-
body responses as well as Th1-and Th2 immune responses to larval proteins [49–51].
In conclusion, we demonstrated that Bm-FAR-1 and Bm-FAR-2 are two FAR proteins with
a similar but slightly different structure, exhibit different expression abundance and lipid-
binding characteristics, and confer different levels of protection against B. malayi infection.
We found a similar dichotomy in ligand binding between the orthologous proteins in O volvu-
lus, which may unexpectedly apply widely amongst filarial nematode parasites. B. malayi
FARs, especially Bm-FAR-1 may play important roles in the survival of the filarial parasite in
the host, therefore are promising vaccine candidates for a prophylactic vaccine against lym-
phatic filariasis.
Supporting information
S1 Fig. Expression of rBm-FAR-2 with His-tag in E. coli BL21 and purified with IMAC.
Lane 1, SDS-PAGE of purified rBm-FAR-2 (2 μg). Lane 2, Western blot of 100 ng of rBm-
FAR-2 probed with anti-His antibody (1:3,000).
(TIF)
S2 Fig. Similarities in the hydrophobic ligand-binding properties of FAR-1 and FAR-2
proteins of B. malayi with orthologous FARs of O. volvulus. Fluorescence emission spectra
were recorded, and spectrofluorimetry conditions set, as described in Materials and Methods.
The ligands were all-trans retinol (A), dansylamino undecanoic acid (DAUDA), a fatty acid
conjugated to the environmentally sensitive dansyl fluorophore (B), and, cis-parinaric acid
(cPnA), a natural fatty acid that is intrinsically fluorescent, the emission of which is, like dan-
syl, environment-sensitive (C). All of the proteins were estimated to be at concentrations of ~4
mg ml-1. These results show that, firstly, the proteins from both parasites bind retinol, though
FAR-2s elicit less of a fluorescence enhancement of retinol than FAR-1s in these experimental
conditions (A). Second, that FAR-1s bind DAUDA, yielding similarly substantial increases
and blue shift in its peak fluorescence emission, but FAR-2s bind elicit only minor changes in
DAUDA fluorescence (B). As said in the main text, this could be because either FAR-2s bind
DAUDA poorly, or that they bind the fatty acid moiety of DAUDA but leave the attached dan-
syl fluorophore exposed to a polar environment. Third, both FAR-1s and FAR-2s bind a natu-
ral, intrinsically fluorescent, fatty acid acid (cPnA), indicating that all of these proteins bind
fatty acids (C). As with retinol, the FAR-2s elicited weaker changes in the emission of cPnA
than the FAR-1s. Note that Bm-FAR-2 is larger than Bm- FAR-1, such that at equivalent w/v
concentrations their molarities will differ. Also, we cannot assume that the proportion of prop-
erly folded and active protein in each protein sample is equivalent, or that there is no interfer-
ence from resident ligand(s) derived from the bacteria in which the proteins were produced.
(TIF)
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